loader
Please Wait
Applying Filters...

Evonik Evonik

X

List of Binimetinib NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 MSN Laboratories Private Limited (1)

filter

01 Binimetinib (1)

filter

01 India (1)

URL Supplier Web Content
Binimetinib
POWDER (1kg/kg)
BULK INGREDIENT
54893-0119
2021-12-09
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 606143-89-9 / Binimetinib API manufacturers, exporters & distributors?

Binimetinib manufacturers, exporters & distributors 1

97

PharmaCompass offers a list of Binimetinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Binimetinib manufacturer or Binimetinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Binimetinib manufacturer or Binimetinib supplier.

PharmaCompass also assists you with knowing the Binimetinib API Price utilized in the formulation of products. Binimetinib API Price is not always fixed or binding as the Binimetinib Price is obtained through a variety of data sources. The Binimetinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Binimetinib

Synonyms

606143-89-9, Mek162, Arry-162, Mektovi, Arry-438162, Mek-162

Cas Number

606143-89-9

Unique Ingredient Identifier (UNII)

181R97MR71

About Binimetinib

Binimetinib is an orally available inhibitor of mitogen-activated protein kinase kinase 1 and 2 (MEK1/2) with potential antineoplastic activity. Binimetinib, noncompetitive with ATP, binds to and inhibits the activity of MEK1/2. Inhibition of MEK1/2 prevents the activation of MEK1/2 dependent effector proteins and transcription factors, which may result in the inhibition of growth factor-mediated cell signaling. This may eventually lead to an inhibition of tumor cell proliferation and an inhibition in production of various inflammatory cytokines including interleukin-1, -6 and tumor necrosis factor. MEK1/2 are dual-specificity threonine/tyrosine kinases that play key roles in the activation of the RAS/RAF/MEK/ERK pathway and are often upregulated in a variety of tumor cell types.

Binimetinib Manufacturers

A Binimetinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Binimetinib, including repackagers and relabelers. The FDA regulates Binimetinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Binimetinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Binimetinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Binimetinib Suppliers

A Binimetinib supplier is an individual or a company that provides Binimetinib active pharmaceutical ingredient (API) or Binimetinib finished formulations upon request. The Binimetinib suppliers may include Binimetinib API manufacturers, exporters, distributors and traders.

click here to find a list of Binimetinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Binimetinib NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Binimetinib as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Binimetinib API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Binimetinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Binimetinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Binimetinib NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Binimetinib suppliers with NDC on PharmaCompass.

Binimetinib Manufacturers | Traders | Suppliers

Binimetinib Manufacturers, Traders, Suppliers 1
53

We have 1 companies offering Binimetinib

Get in contact with the supplier of your choice:

  1. MSN Laboratories
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY